Related Experiment Video
Updated: Jan 30, 2026

Isolation of Mouse Primary Microglia by Magnetic-Activated Cell Sorting in Animal Models of Demyelination
Published on: April 5, 2022
Hydroxyfasudil alleviates demyelination through the inhibition of MOG antibody and microglia activation in cuprizone
Jing Wang1, Ruo-Xuan Sui2, Qiang Miao2
1Shanxi Medical University, Taiyuan030001, China.
Abstract:
Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system characterized by oligodendrocyte loss and progressive neurodegeneration. The cuprizone (CPZ)-induced demyelination is widely used to investigate the demyelination/remyelination. Here, we explored the therapeutic effects of Hydroxyfasudil (HF), an active metabolite of Fasudil, in CPZ model. HF improved behavioral abnormality and reduced myelin damage in the corpus callosum. Splenic atrophy and myelin oligodendrocyte glycoprotein (MOG) antibody were observed in CPZ model, which were partially restored and obviously inhibited by HF, therefore reducing pathogenic binding of MOG antibody to oligodendrocytes. HF inhibited the percentages of CD4+IL-17+ T cells from splenocytes and infiltration of CD4+ T cells and CD68+ macrophages in the brain. HF also declined microglia-mediated neuroinflammation, and promoted the production of astrocyte-derived brain derived neurotrophic factor (BDNF) and regeneration of NG2+ oligodendrocyte precursor cells. These results provide potent evidence for the therapeutic effects of HF in CPZ-induced demyelination.
Insights
Hydroxyfasudil (HF) shows therapeutic potential for multiple sclerosis (MS) by improving behavior and reducing myelin damage in a cuprizone model. It also mitigates immune responses and promotes neural repair, offering hope for MS treatment.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Multiple sclerosis (MS) is a central nervous system disease causing demyelination and neurodegeneration.
- The cuprizone (CPZ) model is crucial for studying demyelination and remyelination processes.
- Understanding therapeutic interventions for MS is critical.
Purpose of the Study:
- To investigate the therapeutic effects of Hydroxyfasudil (HF) in the CPZ-induced demyelination model.
- To assess HF's impact on behavioral abnormalities, myelin damage, and immune responses in MS.
- To explore HF's potential to promote neuroprotection and remyelination.
Main Methods:
- Utilized the cuprizone (CPZ) mouse model to induce demyelination.
- Administered Hydroxyfasudil (HF) to CPZ-treated mice.
- Evaluated behavioral outcomes, myelin integrity (corpus callosum), splenic changes, and antibody levels (MOG).
- Analyzed immune cell populations (CD4+IL-17+ T cells, CD4+ T cells, CD68+ macrophages) in splenocytes and brain tissue.
- Assessed neuroinflammation markers and neurotrophic factor (BDNF) production.
- Quantified oligodendrocyte precursor cell (NG2+) regeneration.
Main Results:
- HF improved behavioral deficits and reduced myelin damage in the corpus callosum of CPZ mice.
- HF partially restored splenic atrophy and inhibited myelin oligodendrocyte glycoprotein (MOG) antibody production, reducing antibody binding to oligodendrocytes.
- HF decreased CD4+IL-17+ T cells, CD4+ T cells, and CD68+ macrophages in the brain, indicating reduced neuroinflammation.
- HF promoted astrocyte-derived brain-derived neurotrophic factor (BDNF) production and enhanced the regeneration of NG2+ oligodendrocyte precursor cells.
Conclusions:
- Hydroxyfasudil (HF) demonstrates significant therapeutic effects in a mouse model of demyelination.
- HF mitigates neuroinflammation, protects myelin, and promotes remyelination by supporting oligodendrocyte precursor cell regeneration.
- These findings suggest HF as a promising candidate for treating multiple sclerosis.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
Enzyme Inhibition
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Co-activators and Co-repressors
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...